Boston Scientific Corp. v. MICRUS CORP.

FIRST CLAIM CONSTRUCTION ORDER

I. INTRODUCTION

Boston Scientific Corp. and Target Therapeutics, Inc. (“Plaintiffs,” or collectively, “Boston Scientific”) bring this action against Micrus Corp. (“Defendant” or “Micrus”) for alleged patent infringement of two patents relating to methods and devices for treating vascular medical problems. Plaintiffs allege that Defendant willfully infringed, and continues to infringe (1) U.S. Patent No. 5,895,385 (the “'385 Patent”) entitled “Endovascular Electrolytieally Detachable Wire and Tip for the Formation of Thrombus in Arteries, Veins, Aneurysms, Vascular Malformations and Arteriovenous Fistulas;” and (2) U.S. Patent No. 6,010,498 (the “'498 Patent”) also entitled “Endovascular Electrolytically Detachable Wire and Tip for the Formation of Thrombus in Arteries, Veins, Aneurysms, Vascular Malformations and Arteriovenous Fistulas.” (See Complaint for Patent Infringement, Docket Item No. 1.)

Micrus has asserted counterclaims that Boston Scientific infringes U.S. Patent Nos. 5,645,558 (the “'558 Patent”) and 5,766,219 (the “'219 Patent”) each entitled “Anatomically Shaped Vasoocclusive Device and Method of Making Same;” and 6,168,615 (the…